Related Experiment Videos
TAK1-binding protein 1 is a pseudophosphatase.
Sarah H Conner1, Gursant Kular, Mark Peggie
1MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK.
The Biochemical Journal
|August 2, 2006
Summary
Transforming growth factor-beta-activated kinase 1-binding protein 1 (TAB1) shares a fold with protein phosphatases but lacks catalytic activity, suggesting it functions as a pseudophosphatase. This protein may regulate substrates or the TAK1 complex itself.
Area of Science:
- Structural Biology
- Molecular Biology
- Biochemistry
Background:
- TAB1 is a regulatory subunit of TAK1, a key kinase in pro-inflammatory pathways.
- TAK1-binding protein 1 (TAB1) plays a crucial role in regulating transforming growth factor-beta-activated kinase 1 (TAK1) signaling.
- TAB1 is essential for TAK1 activation and subsequent pro-inflammatory responses.
Purpose of the Study:
- To determine the crystal structure of the N-terminal domain of TAB1.
- To investigate the potential phosphatase activity of TAB1.
- To elucidate the structural basis for TAB1's function in TAK1 signaling.
Main Methods:
- X-ray crystallography to obtain the N-terminal domain structure of TAB1.
- Biochemical assays using phosphopeptide and p-nitrophenyl phosphate to test for phosphatase activity.
- Site-directed mutagenesis and isothermal titration calorimetry to analyze metal-binding and catalytic residues.
Main Results:
- The N-terminal domain of TAB1 exhibits a fold similar to Mg2+/Mn2+-dependent protein phosphatases, specifically protein phosphatase 2C alpha.
- No detectable phosphatase activity was observed for TAB1 with tested substrates.
- Key catalytic residues for dual metal-binding are absent in TAB1, though single metal binding was confirmed.
Conclusions:
- TAB1 is a structural mimic of a protein phosphatase, classified as a 'pseudophosphatase'.
- TAB1's function likely involves binding to and modulating phosphorylated substrates or the TAK1 complex.
- The pseudophosphatase activity of TAB1 may be critical for fine-tuning TAK1-mediated inflammatory signaling pathways.